212 filings
Page 3 of 11
8-K
k6seo s4rlus7
2 Nov 22
Seres Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
7:10am
8-K
mcw vbzo11en7c
3 Aug 22
Seres Therapeutics Reports Second Quarter 2022 Financial Results and Provides
7:15am
8-K
dn5f 956b3ze3t
30 Jun 22
Entry into a Material Definitive Agreement
8:02am
424B5
ll1 e36lhy1m
30 Jun 22
Prospectus supplement for primary offering
7:59am
8-K
2w6d3f04gyc
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:04pm
8-K
8gyo4
7 Jun 22
Regulation FD Disclosure
7:36am
EFFECT
t2p e151h2a
6 May 22
Notice of effectiveness
12:00am
POS AM
d6on2au
4 May 22
Prospectus update (post-effective amendment)
4:03pm
8-K
frjpac ql
4 May 22
Seres Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates
7:11am
DEFA14A
vdukjig5qi
29 Apr 22
Additional proxy soliciting materials
12:00am
8-K
8ect7xefx69hwvkd
6 Apr 22
Regulation FD Disclosure
7:00am
POS AM
u6ij5bsy5i79nwcg
1 Mar 22
Prospectus update (post-effective amendment)
11:02am
S-8
tumcc1h
1 Mar 22
Registration of securities for employees
10:31am
POSASR
q2n6pv
1 Mar 22
Automatic shelf registration (post-effective amendment)
9:40am
8-K
pfwx 3ex7pf
1 Mar 22
Seres Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
7:07am